2.75
+0.36%
Close of 9 Nov 2026, in HKD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About China Feihe
Its shares trade on HKEX under the ticker 6186.HK. It has been listed since 13 November 2019. In the fiscal year to 31 December 2025, it reported revenue of CN¥21.10bn and net income of CN¥2.26bn. At that date it held total assets of CN¥39.67bn and shareholders' equity of CN¥28.47bn.
China Feihe Ltd. engages in the development, production and sale of infant formula milk and other dairy products. The company is headquartered in Beijing, Beijing. The company went IPO on 2019-11-13. The firm's main products include infant milk formula products, adult milk-powder, liquid milk, goat milk infant formula, and a small amount of soybean powder, among others. The firm's milk formula product series include super-premium Astrobaby, Super-premium Organic Zhenzhi and so on. The firm conducts its businesses within the domestic market and to overseas markets such as the United States.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Consumer Staples
- Industry
- Food Products
- Listed since
- 13 Nov 2019
- Employees
- 5,802
- Website
- feihe.com ↗
Leadership
Pay as last reported
- Mr. Youbin LengExecutive Chairman of the Board, Chief Executive Officer, since 2013CN¥14.2m
- Mr. Fangliang CaiPresident, Executive Director, since 2013CN¥11.3m
- Mr. Hua LiuExecutive Vice Chairman of the Board, Chief Financial Officer, since 2013CN¥5.1m
- Ms. Fong-Yee TuVice President, Executive Director, Company Secretary, since 2013CN¥1.1m
- Mr. Kwok King ChanNon-Executive Director
- Mr. Kwok Wah CheungNon-Executive Director, since 2019CN¥181,000
- Mr. Yu GaoNon-Executive Director
- Mr. Yonghong FanIndependent Non-Executive DirectorCN¥343,000
- Mr. Jacques LaforgeIndependent Non-Executive DirectorCN¥343,000
- Ms. Jinping LiuIndependent Non-Executive DirectorCN¥343,000
- Mr. Jianwu SongIndependent Non-Executive DirectorCN¥343,000
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 74
- Environment
- 99
- Social
- 80
- Governance
- 43
- Direct emissions (scope 1)
- 126,100 t
- Energy emissions (scope 2)
- 60,800 t
- Women in the workforce
- 41.06722%
- Carbon reduction policy
- No
- Human rights policy
- Yes
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- China Feihe Ltd has a strong and recognized presence in the Chinese infant formula market, with a history dating back several decades. This gives the company an advantage over new entrants and establishes trust among consumers.
- Feihe Ltd is known for its high-quality infant formula products, incorporating advanced production technologies and stringent quality control measures. This ensures the safety and nutritional value of their products, contributing to customer loyalty and satisfaction.
- The company has built an extensive distribution network, reaching various regions within China. This allows for efficient and widespread product availability, giving Feihe a competitive edge in capturing market share.
Weaknesses
- China Feihe Ltd's heavy reliance on the Chinese market exposes them to potential risks associated with regulatory changes, market fluctuations, and intense competition within the domestic industry. Diversification into international markets could mitigate this vulnerability.
- The company focuses primarily on infant formula products, which limits their revenue streams and exposes them to market-specific risks. Expanding their product portfolio to include complementary child nutrition products or diversifying into other segments of the baby care market may enhance their growth prospects.
Opportunities
- The demand for infant formula and related products in China is expected to rise due to population growth, increasing disposable incomes, and changing lifestyle patterns. Feihe Ltd can capitalize on this opportunity by leveraging their brand reputation and expanding their market reach.
- Exploring opportunities in foreign markets can provide China Feihe Ltd with new revenue streams and reduce dependence on the Chinese market. Strategic partnerships, acquisitions, or establishing production facilities overseas can facilitate globalization and offer potential growth avenues.
Threats
- The Chinese infant formula market is highly competitive, with both domestic and international players vying for market share. Feihe Ltd faces the threat of losing market position to competitors who offer similar or alternative products, necessitating continuous innovation and differentiation.
- Changes in government regulations and standards for infant formula products can impact manufacturing processes, labeling requirements, and product claims. Feihe Ltd must stay vigilant to comply with regulatory changes promptly and invest in adapting their operations to meet evolving industry standards.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.